Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 59,288 | 44,509 | 4,484 | 20,383 | 28,895 |
| Cost of Goods | 906 | 287 | 0 | 0 | N/A |
| Gross Profit | 58,382 | 44,222 | 4,484 | 20,383 | 28,895 |
| Operating Expenses | 128,379 | 117,192 | 84,100 | 90,124 | 80,638 |
| Operating Income | -69,091 | -72,683 | -79,616 | -69,741 | -51,743 |
| Interest Expense | 335 | 0 | 0 | 0 | 0 |
| Other Income | 2,532 | 2,203 | 1,624 | 525 | 279 |
| Pre-tax Income | -66,894 | -70,480 | -77,992 | -69,216 | -51,464 |
| Net Income Continuous | -66,894 | -70,480 | -77,992 | -69,216 | -51,464 |
| Net Income | $-66,894 | $-70,480 | $-77,992 | $-69,216 | $-51,464 |
| EPS Basic Total Ops | -4.00 | -4.40 | -6.20 | -7.30 | -5.80 |
| EPS Basic Continuous Ops | -4.00 | -4.39 | -6.17 | -7.33 | -5.82 |
| EPS Diluted Total Ops | -4.00 | -4.40 | -6.20 | -7.30 | -5.80 |
| EPS Diluted Continuous Ops | -4.00 | -4.39 | -6.17 | -7.33 | -5.82 |
| EPS Diluted Before Non-Recurring Items | -4.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-69,481 | $-72,855 | $-79,501 | $-68,685 | $-50,304 |